Please contact us for more information or to learn if you are eligible to participate.
The purpose of the study is to evaluate the efficacy, safety and long tolerability of long-term dosing of inclisiran in patient with atherosclerotic cardiovascular disease, hypercholesterolemia and elevated LDL-C (Bad Cholesterol)
Mahesh Changlani, MD
The Medicines Company
Type of Trial